RBC Capital's decision to maintain its Sector Perform rating for Chemours and raise its price target suggests that the company's stock is expected to perform in line with the market. The raised price target indicates a potential upside, but the current share price decline of 3.21% shows that the market may have a mixed reaction to the news. Therefore, the short-term impact on Chemours' stock price is neutral.